Paper33379331
Hepatitis B Virus Cure: Targets and Future Therapies.
Lee HW and 2 others. Int J Mol Sci, 2020. Cited by 87 papers, by iCite.
Cite this record
ConductScience Library. Hepatitis B Virus Cure: Targets and Future Therapies. Papers, record 33379331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33379331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| Hepatitis B | Major topic |
| Hepatitis B virus | Major topic |
| Humans | |
| Molecular Targeted Therapy |
Source PubMed
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28335554 | Complete and Incomplete Hepatitis B Virus Particles: Formation, Function, and Application. | Viruses | 2017 | https://conductscience.org/library/papers/28335554 | PubMed |
| 2 | 25789969 | T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance. | Cell Death Dis | 2015 | https://conductscience.org/library/papers/25789969 | PubMed |
| 3 | 1060140 | Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/1060140 | PubMed |
| 4 | 28833361 | Epigenetic regulation of hepatitis B virus covalently closed circular DNA: Implications for epigenetic therapy against chronic hepatitis B. | Hepatology | 2017 | https://conductscience.org/library/papers/28833361 | PubMed |
| 5 | 24768844 | Strategies to inhibit entry of HBV and HDV into hepatocytes. | Gastroenterology | 2014 | https://conductscience.org/library/papers/24768844 | PubMed |
| 6 | 18524834 | Properties of subviral particles of hepatitis B virus. | J Virol | 2008 | https://conductscience.org/library/papers/18524834 | PubMed |
| 7 | 33222272 | Similarly low risk of hepatocellular carcinoma after either spontaneous or nucleos(t)ide analogue-induced hepatitis B surface antigen loss. | Aliment Pharmacol Ther | 2021 | https://conductscience.org/library/papers/33222272 | PubMed |
| 8 | 32926353 | Bulevirtide: First Approval. | Drugs | 2020 | https://conductscience.org/library/papers/32926353 | PubMed |
| 9 | 26239691 | Present and future therapies of hepatitis B: From discovery to cure. | Hepatology | 2015 | https://conductscience.org/library/papers/26239691 | PubMed |
| 10 | 30861337 | A Randomized, Double-Blind, Placebo-Controlled, First-Time-in-Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of GSK3389404 in Healthy Subjects. | Clin Pharmacol Drug Dev | 2019 | https://conductscience.org/library/papers/30861337 | PubMed |
| 11 | 29104121 | Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B. | J Hepatol | 2018 | https://conductscience.org/library/papers/29104121 | PubMed |
| 12 | 17045625 | Enzymatic treatment of duck hepatitis B virus: topology of the surface proteins for virions and noninfectious subviral particles. | Virology | 2007 | https://conductscience.org/library/papers/17045625 | PubMed |
| 13 | 29337856 | Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B. | Vaccines (Basel) | 2018 | https://conductscience.org/library/papers/29337856 | PubMed |
| 14 | 25904148 | Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome. | J Gen Virol | 2015 | https://conductscience.org/library/papers/25904148 | PubMed |
| 15 | 30625297 | Antiviral Activity, Safety, and Pharmacokinetics of Capsid Assembly Modulator NVR 3-778 in Patients with Chronic HBV Infection. | Gastroenterology | 2019 | https://conductscience.org/library/papers/30625297 | PubMed |
| 16 | 31654573 | RNA Interference Therapy With ARC-520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection. | Hepatology | 2020 | https://conductscience.org/library/papers/31654573 | PubMed |
| 17 | 31306680 | Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: A pilot study. | J Hepatol | 2019 | https://conductscience.org/library/papers/31306680 | PubMed |
| 18 | 30114488 | Spontaneous Seroclearance of Hepatitis B Surface Antigen and Risk of Hepatocellular Carcinoma. | Clin Gastroenterol Hepatol | 2019 | https://conductscience.org/library/papers/30114488 | PubMed |
| 19 | 23639914 | T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice. | Gastroenterology | 2013 | https://conductscience.org/library/papers/23639914 | PubMed |
| 20 | 30801899 | Therapeutic vaccination for chronic hepatitis B: A systematic review and meta-analysis. | J Viral Hepat | 2019 | https://conductscience.org/library/papers/30801899 | PubMed |
Cited by61
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42671026 | The Significance of cGAS-STING Signaling in Response to Oncogenic Viruses. | Cell Biochem Funct | 2026 | https://conductscience.org/library/papers/42671026 | PubMed |
| 42516138 | Establishment of prognostic nomogram in cervical cancer with hepatitis B virus infection: a retrospective study. | Front Oncol | 2026 | https://conductscience.org/library/papers/42516138 | PubMed |
| 42503910 | [Distribution of serum HBV RNA in the natural history of chronic HBV infection and factors influencing HBV RNA negativity: a retrospective study stratified by HBeAg status]. | Zhonghua Gan Zang Bing Za Zhi | 2026 | https://conductscience.org/library/papers/42503910 | PubMed |
| 42233029 | Emerging antiviral drugs and immunotherapy for chronic hepatitis B and associated liver disease. | Front Immunol | 2026 | https://conductscience.org/library/papers/42233029 | PubMed |
| 41817955 | Navigating the Viral Hepatitis Drug Landscape: New Discoveries and Enduring Challenges. A Narrative Review. | Infect Dis Ther | 2026 | https://conductscience.org/library/papers/41817955 | PubMed |
| 41809484 | Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B. | World J Hepatol | 2026 | https://conductscience.org/library/papers/41809484 | PubMed |
| 41624844 | Combined therapy with the estrogen receptor ERα and IFNα-2b suppresses HBV replication by inducing GBP1 expression. | Front Immunol | 2025 | https://conductscience.org/library/papers/41624844 | PubMed |
| 41430687 | Molecular mechanism of RBM15-mediated m6A modification in hepatitis B virus replication. | Virol J | 2025 | https://conductscience.org/library/papers/41430687 | PubMed |
| 41295547 | Hepatitis Vaccines: Recent Advances and Challenges. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41295547 | PubMed |
| 40877512 | Generating mRNA Encoding Anti-HBV Designer Epigenome Modifiers. | Methods Mol Biol | 2025 | https://conductscience.org/library/papers/40877512 | PubMed |
| 40790753 | Pathogenesis, prevention, and therapeutic advances in hepatitis B, C, and D. | Virol J | 2025 | https://conductscience.org/library/papers/40790753 | PubMed |
| 40771315 | Exosome in HBV infection: current concepts and future perspectives. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/40771315 | PubMed |
| 40689368 | Indian National Association for the Study of the Liver Position Statements on Prevention, Diagnosis, and Management of Hepatitis B Virus Infection in India. | J Clin Exp Hepatol | 2025 | https://conductscience.org/library/papers/40689368 | PubMed |
| 40571844 | HBV infection upregulates GP73 expression to promote liver fibrosis by enhancing ER stress via the Smad2 pathway. | Immunol Res | 2025 | https://conductscience.org/library/papers/40571844 | PubMed |
| 40426198 | Nanoparticle-mediated SIRT1 inhibition suppresses M2 macrophage polarization and hepatocarcinogenesis in chronic hepatitis B. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/40426198 | PubMed |
| 40352669 | Salicylamide derivatives as potent HBV inhibitors: insights into structure-activity relationships. | RSC Med Chem | 2025 | https://conductscience.org/library/papers/40352669 | PubMed |
| 40341244 | Association between resolved hepatitis B virus infection and depression in American adults : a cross-sectional study. | Sci Rep | 2025 | https://conductscience.org/library/papers/40341244 | PubMed |
| 40205504 | USP21 is involved in the development of chronic hepatitis B by modulating the immune microenvironment. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/40205504 | PubMed |
| 40005578 | Contrasting Effect of Curcumin on Hepatitis B Virus Replication According to the Hepatoma Cell Line. | Pathogens | 2025 | https://conductscience.org/library/papers/40005578 | PubMed |
| 39860969 | Surveillance Following Hepatitis B Surface Antigen Loss: An Issue Requiring Attention. | Pathogens | 2024 | https://conductscience.org/library/papers/39860969 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| IL12B | 3593 | PubTator's text mining | https://conductscience.org/library/genes/3593 | NCBI Gene |
| NR1I3 | 9970 | PubTator's text mining | https://conductscience.org/library/genes/9970 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
| SLC10A1 | 6554 | PubTator's text mining | https://conductscience.org/library/genes/6554 | NCBI Gene |
| TLR7 | 51284 | PubTator's text mining | https://conductscience.org/library/genes/51284 | NCBI Gene |
| TRBV20OR9-2 | 6962 | PubTator's text mining | https://conductscience.org/library/genes/6962 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33379331
GET https://conductscience.org/api/papers/v1/33379331/references?page=2